Crescent Capital Group LP, a leading alternative credit investment firm, announced today that its European Specialty Lending strategy has provided financing to support the acquisition of AIO II by funds managed by Bencis Capital Partners and management. Crescent is also providing financing to support AIO II’s ongoing buy and build efforts. Terms of the transaction were not disclosed.
AIO II operates a chain of over 50 pharmacies across the Netherlands (Medsen) plus a modern large-scale compounding pharmacy (Ceban).
“By providing this critical financing for the acquisition of AIO II, which operates in a fragmented landscape, the company can continue to execute on its buy and build growth trajectory,” said Christine Vanden Beukel, Managing Director and head of Crescent’s European Specialty Lending strategy. “We are proud to have been able to provide this two-part financing, which is demonstrative of the types of flexible capital we provide to companies and sponsors.”
Date: February 25, 2019
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: AP News
